Stay updated on Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:32:59.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:48:01.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The revision is updated to v3.4.3, replacing the previous v3.4.2 entry.
    Difference
    0.1%
    Check dated 2026-03-11T16:43:42.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the government-funding operating-status notice and prior revision (v3.4.1); these are administrative site updates that do not alter study content, endpoints, or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T09:22:22.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Notice about lapse in government funding added and page revision updated to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T05:41:18.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    These are minor UI and metadata updates: a glossary display option was added, and labels such as 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' were introduced with minor capitalization changes (e.g., 'No FEAR Act data'). They do not affect core study content, eligibility criteria, endpoints, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T03:24:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Radiation in Metastatic GI Cancer Clinical Trial page.